Completed PHASE4 INTERVENTIONAL 2-arm NCT00377611

Study on the Incidence of Influenza and Its Complications, in Subjects Aged 50 Years and Over Vaccinated With Fluarix™

A Study to Investigate the Incidence of Influenza and Influenza-related Complications, in Adults Between 50-64 Years and Elderly Adults 65 Years and Over Vaccinated With Fluarix™

Sponsor: GlaxoSmithKline

Conditions Influenza

Interventions Fluarix™

Updated 9 times since 2017 Last updated: Jun 15, 2018 Started: Oct 5, 2006 Primary completion: Jun 20, 2007 Completion: Jun 20, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Influenza, this trial is completed. The trial is conducted by GlaxoSmithKline and has accumulated 9 data snapshots since 2006. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Dec 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Dec 2021 [monthly]

Completed PHASE4

▶ Show 4 earlier versions

Nov 2018 — Jan 2021 [monthly]

Completed PHASE4
Jun 2018 — Nov 2018 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Oct 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

GlaxoSmithKline

Data source: GlaxoSmithKline

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Berlin, Germany , Camillus, United States , Delray Beach, United States , Dresden, Germany , Dębica, Poland , Essen, Germany , Frankfurt am Main, Germany , Güglingen, Germany , Hamburg, Germany , Krakow, Poland and 21 more locations